Rubella E1

Rubella Virus E1 Mosaic Recombinant
Cat. No.
BT217
Source
Synonyms
Appearance
Purity

Protein is >90% pure as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The E.Coli derived recombinant protein contains the Rubella Virus E1 regions, 157-176, 374-390, 213-239 amino acids. The protein is fused to a GST-tag.

Product Specs

Introduction
Rubella virus is an enveloped positive-strand RNA virus of the family Togaviridae. Virions are composed of three structural proteins: a capsid and two membrane-spanning glycoproteins, E2 and E1. During virus assembly, the capsid interacts with genomic RNA to form nucleocapsids. The rubella virus (RV) structural proteins: capsid, E2, and E1 are synthesized as a polyprotein precursor. The signal peptide that initiates translocation of E2 into the lumen of the endoplasmic reticulum remains attached to the carboxy terminus of the capsid protein after cleavage by signal peptidase.
Description
The E. coli-derived recombinant protein contains the Rubella Virus E1 regions, amino acids 157-176, 374-390, and 213-239. The protein is fused to a GST-tag.
Purity
Protein is greater than 90% pure as determined by SDS-PAGE.
Formulation
1x PBS.
Stability
Rubella E1 Protein, although stable at 4°C for 1 week, should be stored below -18°C. Please prevent freeze-thaw cycles.
Applications
Rubella antigen is suitable for ELISA and Western blots, and is an excellent antigen for the detection of Rubella Virus with minimal specificity problems.
Purification Method
Rubella protein was purified by proprietary chromatographic technique.
Specificity
Immunoreactive with sera of Rubella Virus infected individuals.

Product Science Overview

Introduction

Rubella virus (RuV) is an enveloped, positive-sense RNA virus belonging to the Rubivirus genus. It is the causative agent of rubella, also known as German measles, a contagious disease that can lead to severe birth defects if contracted by pregnant women. The E1 glycoprotein of RuV plays a crucial role in the virus’s ability to infect host cells and is a key target for vaccine development.

Preparation Methods

The preparation of Rubella Virus E1 Mosaic Recombinant involves the use of recombinant DNA technology. This process typically includes:

  1. Cloning: The gene encoding the E1 glycoprotein is cloned into an expression vector.
  2. Expression: The recombinant vector is introduced into a suitable host cell line, such as E. coli or mammalian cells, to express the E1 protein.
  3. Purification: The expressed E1 protein is then purified using techniques such as affinity chromatography.
  4. Characterization: The purified protein is characterized to confirm its identity and functionality.
Biological Properties

The E1 glycoprotein is an integral membrane protein that mediates the fusion of the viral envelope with the host cell membrane, facilitating viral entry. It is also involved in the assembly and release of new viral particles. The E1 protein contains several epitopes that are recognized by the immune system, making it a critical component of the immune response to RuV infection.

Functions

The primary function of the E1 glycoprotein is to facilitate the entry of the rubella virus into host cells. It does this by binding to specific receptors on the surface of the host cell and mediating the fusion of the viral envelope with the host cell membrane. This fusion process is pH-dependent and occurs in the acidic environment of the endosome.

Modes of Action

The E1 glycoprotein undergoes conformational changes in response to the acidic pH of the endosome, which triggers the fusion of the viral envelope with the endosomal membrane. This fusion event releases the viral RNA into the host cell cytoplasm, where it can be translated and replicated to produce new viral particles.

Regulatory Mechanisms

The expression and function of the E1 glycoprotein are tightly regulated by both viral and host factors. Post-translational modifications, such as glycosylation, play a significant role in the proper folding and functionality of the E1 protein. Additionally, the interaction of E1 with other viral proteins, such as the E2 glycoprotein, is essential for the assembly and release of infectious viral particles.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.